COPD volunteers
June 22, 2010
GLAXOSMITHKLINE is asking
pharmacists to help identify
Australians with either asthma or
chronic obstructive pulmonary
disease (smokers cough or
emphysema), to take part in three
new international medication
research studies.
“Pharmacists are well placed to
identify those patients whose
condition is not adequately
controlled and may benefit from
participating in a study investigating
new treatment options,” said Prof.
Philip Bardin, Respiratory Specialist
at Monash University.
Basically the study will require
patients aged 12 years and over
with asthma and 40 years and over
with COPD to trial a new once daily
inhaler therapy.
“Current treatments for asthma
and COPD require patients to take
their medicine twice daily, which
can lead to issues with compliance
if people forget to take their
medication,” said Bardin.
“The inhaler therapy being tested
in these international studies
requires only once-a-day usage that
may help to improve regular use of
the medicine and longer-term
management of disease,” he added.
For more info call 1800 800 285.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Jun 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Jun 10
